141 related articles for article (PubMed ID: 9205000)
21. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
[TBL] [Abstract][Full Text] [Related]
22. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
[TBL] [Abstract][Full Text] [Related]
23. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
Scheffer GL; Kool M; Heijn M; de Haas M; Pijnenborg AC; Wijnholds J; van Helvoort A; de Jong MC; Hooijberg JH; Mol CA; van der Linden M; de Vree JM; van der Valk P; Elferink RP; Borst P; Scheper RJ
Cancer Res; 2000 Sep; 60(18):5269-77. PubMed ID: 11016657
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.
Rao VV; Anthony DC; Piwnica-Worms D
J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634
[TBL] [Abstract][Full Text] [Related]
25. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
Tijerina M; Fowers KD; Kopecková P; Kopecek J
Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas.
Tanaka Y; Abe Y; Tsugu A; Takamiya Y; Akatsuka A; Tsuruo T; Yamazaki H; Ueyama Y; Sato O; Tamaoki N
Virchows Arch; 1994; 425(2):133-8. PubMed ID: 7952498
[TBL] [Abstract][Full Text] [Related]
27. A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets.
Ford J; Hoggard PG; Owen A; Khoo SH; Back DJ
J Immunol Methods; 2003 Mar; 274(1-2):129-37. PubMed ID: 12609539
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies as a tool for structure-function studies of the MDR1-P-glycoprotein.
Cianfriglia M; Cenciarelli C; Barca S; Tombesi M; Flego M; Dupuis ML
Curr Protein Pept Sci; 2002 Oct; 3(5):513-30. PubMed ID: 12369999
[TBL] [Abstract][Full Text] [Related]
29. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
30. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
31. [Mechanism of multidrug resistant tumors and chemotherapeutic approaches against the resistant tumors].
Tsuruo T
Yakugaku Zasshi; 1997 Aug; 117(8):455-67. PubMed ID: 9306724
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
Liu B; Sun D; Xia W; Hung MC; Yu D
J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
[TBL] [Abstract][Full Text] [Related]
33. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
34. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
35. Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines.
Berger W; Elbling L; Minai-Pour M; Vetterlein M; Pirker R; Kokoschka EM; Micksche M
Int J Cancer; 1994 Dec; 59(5):717-23. PubMed ID: 7960246
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment.
Fardel O; Lecureur V; Corlu A; Guillouzo A
Biochem Pharmacol; 1996 Jun; 51(11):1427-36. PubMed ID: 8630083
[TBL] [Abstract][Full Text] [Related]
37. Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein.
Nishioka Y; Sone S; Heike Y; Hamada H; Ariyoshi K; Tsuruo T; Ogura T
Jpn J Cancer Res; 1992 Jun; 83(6):644-9. PubMed ID: 1353755
[TBL] [Abstract][Full Text] [Related]
38. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.
Wishart GC; Plumb JA; Going JJ; McNicol AM; McArdle CS; Tsuruo T; Kaye SB
Br J Cancer; 1990 Nov; 62(5):758-61. PubMed ID: 1978783
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies.
Flens MJ; Scheffer GL; van der Valk P; Broxterman HJ; Eijdems EW; Huysmans AC; Izquierdo MA; Scheper RJ
Int J Cancer; 1997 Oct; 73(2):249-57. PubMed ID: 9335451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
